Mankind Pharma Limited

Mankind Pharma Limited (MANKIND) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

mankindpharma.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹2368.80
Market cap
98,830 Cr
Stock P/E
50.4
P/B
5.90
Dividend yield
0.0%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales2,708 Cr2,607 Cr2,441 Cr2,893 Cr3,077 Cr3,230 Cr3,079 Cr3,570 Cr3,697 Cr3,567 Cr3,443 Cr4,031 Cr
Operating expenses (approx.)2,025 Cr2,000 Cr1,850 Cr2,212 Cr2,226 Cr2,400 Cr2,396 Cr2,724 Cr2,776 Cr2,648 Cr2,513 Cr2,974 Cr
EBITDA683 Cr607 Cr591 Cr682 Cr850 Cr830 Cr683 Cr847 Cr921 Cr919 Cr930 Cr1,056 Cr
OPM %25.2%23.3%24.2%23.6%27.6%25.7%22.2%23.7%24.9%25.8%27.0%26.2%
Other income60 Cr70 Cr92 Cr101 Cr109 Cr77 Cr251 Cr80 Cr92 Cr73 Cr114 Cr45 Cr
Interest9 Cr9 Cr9 Cr11 Cr7 Cr221 Cr191 Cr171 Cr170 Cr157 Cr142 Cr110 Cr
Depreciation96 Cr110 Cr105 Cr108 Cr106 Cr192 Cr231 Cr219 Cr222 Cr223 Cr223 Cr226 Cr
Profit before tax641 Cr562 Cr572 Cr668 Cr849 Cr497 Cr508 Cr540 Cr624 Cr509 Cr659 Cr769 Cr
Tax %20.3%18.2%16.6%18.7%22.4%22.7%17.0%17.7%16.6%18.7%15.1%25.4%
Net profit511 Cr460 Cr477 Cr543 Cr659 Cr385 Cr425 Cr445 Cr520 Cr414 Cr559 Cr574 Cr
EPS (₹)₹12.51₹11.33₹11.76₹13.39₹16.31₹9.45₹10.19₹10.62₹12.39₹9.90₹13.44₹13.76

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2023Mar 2024Mar 2025Mar 2026TTM
Sales8,749 Cr10,335 Cr12,207 Cr14,278 CrSign in for TTM
Operating expenses (approx.)6,849 Cr7,800 Cr9,190 Cr10,660 CrSign in for TTM
EBITDA1,901 Cr2,535 Cr3,018 Cr3,617 CrSign in for TTM
OPM %21.7%24.5%24.7%25.3%Sign in for TTM
Other income129 Cr281 Cr537 Cr359 CrSign in for TTM
Interest44 Cr34 Cr429 Cr639 CrSign in for TTM
Depreciation326 Cr398 Cr621 Cr886 CrSign in for TTM
Profit before tax1,671 Cr2,399 Cr2,513 Cr2,333 CrSign in for TTM
Tax %21.6%19.1%20.3%16.9%Sign in for TTM
Net profit1,310 Cr1,942 Cr2,011 Cr1,938 CrSign in for TTM
EPS (₹)₹32.00₹47.75₹49.28₹46.35Sign in for TTM
Dividend payout %0.0%0.0%0.0%2.1%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2023Mar 2024Mar 2025Mar 2026
Equity capital40 Cr40 Cr41 Cr41 Cr
Reserves7,395 Cr9,323 Cr14,291 Cr16,259 Cr
Borrowings170 Cr207 Cr8,511 Cr6,312 Cr
Other liabilities1,922 Cr2,180 Cr4,680 Cr5,207 Cr
Total liabilities9,715 Cr11,963 Cr27,760 Cr28,080 Cr
Fixed assets (net)2,524 Cr2,932 Cr2,908 Cr2,960 Cr
CWIP493 Cr207 Cr306 Cr655 Cr
Investments1,352 Cr2,573 Cr2,042 Cr1,985 Cr
Loans & advances2 Cr3 Cr4 Cr4 Cr
Inventories1,498 Cr1,553 Cr2,094 Cr2,144 Cr
Trade receivables576 Cr848 Cr1,538 Cr1,730 Cr
Cash & bank305 Cr382 Cr407 Cr392 Cr
Other assets2,965 Cr3,465 Cr18,460 Cr18,210 Cr
Total assets9,715 Cr11,963 Cr27,760 Cr28,080 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity1,813 Cr2,152 Cr2,413 Cr3,121 Cr
Cash from investing-1,054 Cr-2,082 Cr-12,683 Cr-196 Cr
Cash from financing-740 Cr5 Cr10,290 Cr-2,953 Cr
Net cash flow22 Cr77 Cr22 Cr-12 Cr
Free cash flow (OCF − Capex)981 Cr1,770 Cr1,893 Cr2,384 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2023Mar 2024Mar 2025Mar 2026
ROCE %22.0%24.9%12.7%13.0%
ROE %16.8%20.0%13.6%11.6%
Debtor days24304644
Inventory days301306378341
Days payable202217205213
Cash conversion cycle122119219172
Debt / equity0.020.020.590.39
Current ratio2.383.141.271.10
Net debt / EBITDA-0.07-0.072.691.64

Compare with peers

Loading peers…